<html>
<head>PUBMED IDs for SRCIN1</head>
<body bgcolor='#C5F0F2'><h1>SRCIN1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/24456795/'>miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.</a> May 6  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24456789/'>Variants in the 5'-upstream region of GPC5 confer risk of lung cancer in never smokers.</a> November 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25554419/'>miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer.</a> April 11  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26408183/'>MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.</a> January 31  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27913185/'>MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.</a> December 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28550679/'>Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression By MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells.</a> May 28  2017<br></body></html>
